Regarding immune checkpoint genes, CD276 and NRP1 are positively correlated with the genes in our model, while TNFSF14 shows a negative correlation with these genes in the tumor immune microenvironment of high-risk patients. This evidence concerns the gene CD276 and neoplasm.